US OptionsDetailed Quotes
GLUE241220C22500
- 0.50
- 0.000.00%
15min DelayClose Nov 22 16:00 ET
0.00High0.00Low
0.50Open0.50Pre Close0 Volume10 Open Interest22.50Strike Price0.00Turnover278.57%IV170.91%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier28DDays to Expiry0.50Extrinsic Value100Contract SizeAmericanOptions Type0.1907Delta0.0416Gamma16.98Leverage Ratio-0.0319Theta0.0009Rho3.24Eff Leverage0.0064Vega
Monte Rosa Therapeutics Stock Discussion
Monte Rosa Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Venture Capital VI, L.P.(6.6%),Versant Ventures VI GP, L.P.(6.6%), etc.
Monte Rosa Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.
No comment yet